Results 191 to 200 of about 30,778 (256)

SSTR-directed peptide receptor radionuclide therapy for recurrent meningiomas: analysis of safety, efficacy and prognostic factors. [PDF]

Eur J Nucl Med Mol Imaging
Hasenauer N, Müller M, Hänscheid H, Serfling SE, Michalski K, Heinrich M, Polat B, Buck AK, Werner RA, Hartrampf PE.   +9 more
europepmc   +1 more source

Peptide Receptor Radionuclide Therapy in Patients with Advanced, Recurrent or Progressive Meningioma: An Updated Systematic Review and Meta-Analysis. [PDF]

Cancers (Basel)
Muoio B, Iacovitti CM, Bosetti DG, Sansovini M, Cuzzocrea M, Paone G, Treglia G.   +6 more
europepmc   +1 more source

Targeted radionuclide therapy for patients with central nervous system metastasis: Overlooked potential? [PDF]

Neuro Oncol
Le Rhun E, Albert NL, Hüllner M, Franceschi E, Galldiks N, Karschnia P, Minniti G, Weiss T, Preusser M, Ellingson BM, Weller M.   +10 more
europepmc   +1 more source

Evaluation of ¹⁷⁷Lu-Labeled Lipiodol as a Targeted Radionuclide Therapy for Hepatocellular Carcinoma in a Preclinical Xenograft Model. [PDF]

Mol Imaging Biol
Kono Y, Utsunomiya K, Shiraishi T, Kan N, Shiojima I, Maruyama K, Tanigawa N.   +6 more
europepmc   +1 more source

The PANEN nomogram: clinical decision support for patients with metastatic pancreatic neuroendocrine neoplasm referred for peptide receptor radionuclide therapy. [PDF]

Front Endocrinol (Lausanne)
Singh A, Sanduleanu S, Kulkarni HR, Langbein T, Lambin P, Baum RP.   +5 more
europepmc   +1 more source

Chronic Prostate Cancer-Related Symptoms and Toxicities Following Stereotactic Body Radiation Therapy: Implications for Future Radionuclide Therapy. [PDF]

Cureus
Kallam D, Gaudian K, Collins R, Zwart Z, Koh MJ, Danner MT, Zwart AL, Kumar D, Simeng S, Gudenkauf L, Fallick M, Esposito G, Gonzalez B, Collins S.   +13 more
europepmc   +1 more source

Considerations for Establishing Peptide Receptor Radionuclide Therapy: A Nationally Coordinated, Collaborative, and Equitable Service for New Zealand. [PDF]

World J Nucl Med
Steyn R, Henderson A, Wells K, Mead T, Rennie Y, Hull A, Meredith L, Sullivan M, Simmers S, Davidson J, Hauraki T, Damianovich D, Boyle V, Lawrence B.   +13 more
europepmc   +1 more source

Corrigendum to “Alpha Atlas: Mapping global production of α-emitting radionuclides for targeted alpha therapy” [Nucl Med Biol (March–April 2025) 108990]

Marianna Tosato, Chiara Favaretto, Janke Kleynhans, Andrew R. Burgoyne, Jean‐François Gestin, Nicholas P. van der Meulen, Amir Reza Jalilian, U. Köster, Mattia Asti, Valery Radchenko   +9 more
openalex   +1 more source

Case report: Resolution of VIPoma-related symptoms with peptide receptor radionuclide therapy. [PDF]

Front Oncol
Cengiz TB, Kulkarni R, Corbett V, Ghesani NV, Wolin E, Ghesani MV.   +5 more
europepmc   +1 more source

Targeted radionuclide therapy for patients with neuroendocrine tumours with focus on normal tissue response in 177-Lu-DOTATATE treatment

, 2016
Johanna Svensson
openalex   +1 more source